Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trials
CRO
Private equity firm acquires CRO CenExel
Boston-based BayPine has acquired a majority stake in the company, leaving former majority owner Webster Equity Partners with a minority stake.
Darren Incorvaia
Apr 15, 2025 12:50pm
UK rolls out new clinical trial reforms
Apr 14, 2025 1:55pm
myTomorrows, recordkeeper team up to match patients with trials
Feb 26, 2025 12:30pm
Clinical trial org Flourish Research buys Diablo
Feb 19, 2025 6:00pm
NIH clarifies how the HHS freeze impacts the division
Jan 27, 2025 5:45pm
New multisite research corporation trade association launches
Jan 23, 2025 12:01am
